Exabis Library
Welcome to the e-CCO Library!
P152: Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn’s disease patients after induction therapy with infliximab
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P152: Faecal calprotectin 100 ug/g and 50 ug/g predict endoscopic and histologic remission: a prospective study in quiescent ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P152: Fatty liver disease in IBD patients as a part of extraintestinal manifestations
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P152: Fertility and reproduction in a tertiary IBD centre: the Oxford experience
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P152: Impact of disease location on burden of illness in patients with moderate-severe Crohn’s disease: A real-world survey in the United States, France, Germany, Italy, Spain, and United Kingdom (5EU)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P152: Reconsidering the prognostic value of traditional serologic antibodies in Crohn's disease – immunoglobulin classes to take the centre stage
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P152: The prevalence of Thiopurine-methyltransferase and NUTD15 in patient with ulcerative colitis: a hospital-based study in central Taiwan
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P153 Fertility rate in women with IBD is decreased compared with general population: first multicentre survey in the Czech Republic
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P153: Association between ustekinumab trough concentrations and clinical, biochemical, and endoscopic outcomes in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P153: IBD patients’ treatment preferences are heterogeneous, but largely affected by the avoidance of abdominal pain and side effects (P-POWER IBD study)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P153: Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P153: Role of 3D endoanal ultrasound in perianal fistulising Crohns's disease. Preliminary results
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P153: The air-enema image of ultra-low-dose CT colonography can be an alternative diagnostic technique for the assessment of mucosal healing in the patients with ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P153: The impact of seton use on clinical and patient-reported outcomes in Crohn’s disease perianal fistulas: findings from a systematic literature review
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P153: Type of treating physician is associated with long-term disease outcome in the prospective Belgian paediatric Crohn’s disease registry
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P154 Sinusitis Prompts Evaluation for Co-existing or Subsequent inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P154: A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P154: Clinical assessment of prognosis and the prognostic factors in intestinal Bahcet’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P154: Complete sequence-based NUDT15 and TPMT variants for predicting thiopurine-induced leukopenia in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P154: Development of a novel ultrasound based score for assessing disease activity in ulcerative colitis: preliminary results
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM